Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
HDFC grp m-cap crosses Rs 10 tn

2018-07-11 freepressjournal.in
Mumbai : Deepak Parekh-led financial services conglomerate HDFC group saw the market capitalisation of its listed firms cross Rs 10 lakh crore mark, making it only the second Indian business house after Tatas to achieve this feat.
GRUH HDB 500180 GRHFY HDFCBANK 511288

1
HDFC group m-cap crosses Rs 10 trillion, only second after Tatas

2018-07-10 moneycontrol
Deepak Parekh-led financial services conglomerate HDFC group today saw the market capitalisation of its listed firms cross Rs 10 lakh crore mark, making it only the second Indian business house after Tatas to achieve this feat. HDFC group currently has four listed entities -- housing finance major HDFC Ltd, banking behemoth HDFC Bank, life insurance firm HDFC Standard Life and Gruh Finance -- while Tatas have nearly 30 firms listed on the stock exchange.
GRUH 532540 HDB 500180 GRHFY HDFCBANK TCS TTNQY 511288

1
HDFC Group’s market cap crosses ₹ 10 trillion, Tata Group at ₹ 11 trillion

2018-07-10 livemint
New Delhi: Deepak Parekh-led financial services conglomerate HDFC Group on Tuesday saw the market capitalisation of its listed firms cross the ₹ 10 trillion mark, making it only the second Indian business house after the Tata group to achieve this feat. HDFC Group has four listed companies—Housing Finance Development Corp. Ltd, HDFC Bank Ltd, life insurance firm HDFC Standard Life Ltd and Gruh Finance Ltd.
GRUH HDFCNIFETF 532540 HDB 500180 GRHFY HDFCBANK TCS TTNQY 539516 511288

21
Market Live: Nifty struggles below 10,800; Jhunjhunwala says 2018 is the year of consolidation

2018-06-21 moneycontrol
KNR in focus: In a clarification note to the exchanges regarding "Promoters of Company taking large interest free loan from the Company", KNR Constructions said the promoters have extended unsecured loan of Rs 214.08 crore to the company, at the interest rate of 8.45 percent per annum to defray the term loan of one of the SPV. "There are no loans and advances given by the Company to promoters."
OPTOCIRCUI 500325 RELIANCE IDBI 539254 533155 JUBLFOOD 511288 CMQMY RIGD JBLWY CUMMINSIND HDFCBANK 500378 RLNIY SBAZ ADANITRANS GRUH INDIGO 500116 534690 IBN GRHFY 532942 539207 539448 KNRCON 500480 ICICIBANK LAKSHVILAS HDB 532174 500180 JINDALSAW 532391 MANPASAND

12
Market Live: Sensex consolidates amid global trade war fears; ICICI Bank, RIL most active

2018-06-21 moneycontrol
India signs MOUs for early adoption of 5G: India signed three memoranda of understanding with three top UK academic institutions to facilitate meaningful exploration and early adoption of 5G technology.
GRUH OPTOCIRCUI INDIGO 500116 IBN IDBI 539254 GRHFY 533155 JUBLFOOD 511288 539448 500480 ICICIBANK CMQMY 532174 JINDALSAW JBLWY 532391 CUMMINSIND 500378 SBAZ ADANITRANS

12
Market Live: Sensex opens up 100 pts, Nifty nears 10,800; ICICI Bank, InterGlobe rally

2018-06-21 moneycontrol
Rupee Update: The rupee slipped 12 paise to 68.20 against the US dollar due to fresh buying of the American currency by importers amid sustained foreign fund outflows. Forex dealers said the dollar hovering near an 11-month high against a basket of currencies overseas, supported by a rise in US yields, also weighed on the rupee but a higher opening of the domestic equity markets limited the fall. Foreign portfolio investors (FPIs) sold shares worth Rs 2,442.
GRUH OPTOCIRCUI INDIGO 500116 IBN IDBI 539254 GRHFY 533155 JUBLFOOD 511288 539448 500480 ICICIBANK CMQMY 532174 JINDALSAW JBLWY 532391 CUMMINSIND 500378 SBAZ ADANITRANS

0
Gruh Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

0
Analysts see tough days ahead for housing finance companies

2018-06-08 thehindubusinessline
Our Bureau Share prices of housing finance companies will remain under pressure on margin concerns due to rising bond yields, say analysts.
GRUH GICHSGFIN DHFL 511072 LICHSGFIN GRHFY 535322 LHFLY 511676 500253 511288 REPCOHOME

0
Gruh Finance Limited - Allotment of Securities

2018-06-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

0
Gruh Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

34
Market Update: HDFC Bank jumps 2%, hits fresh 52-week high; Rcom jumps 10%

2018-05-31 moneycontrol
The broader indices are trading on a positive note this Thursday morning with the Nifty up 26 points at 10,641 and the Sensex trading higher by 88 points at 34,994.
BHRYY 500325 BHUSANSTL RELIANCE ICLQY 533155 532712 BHRQY TTNQY JUBLFOOD 533278 511288 500470 532540 RCOM 534816 RIGD JBLWY HDFCBANK GAILF INFRATEL BHARTIARTL CLNDY 500055 RLNIY GRUH KMBKY GRHFY 532822 539207 532454 TTST TATASTEEL TATLY HDB 500180 GAILY KOTAKBANK IDEA TCS 500247 COALINDIA MANPASAND

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...